Cellular cardiomyoplasty: clinical application
Chachques JC, Acar C, Herreros J, Trainini JC, Prosper F, D'Attellis N, Fabiani JN, Carpentier AF.
Department of Cardiovascular Surgery, European Hospital Georges Pompidou, University of Paris, Paris, France.
Magazine: The Annals of Thoracic Surgery
Date: Mar 1, 2004Cell Therapy Area [SP]
Myocardial regeneration can be induced with the implantation of a variety of myogenic and angiogenic cell types.
More than 150 patients have been treated with cellular cardiomyoplasty worldwide, 18 patients have been treated by our group. Cellular cardiomyoplasty seems to reduce the size and fibrosis of infarct scars, limit postischemic remodelling, and restore regional myocardial contractility.
Techniques for skeletal myoblasts culture and ex vivo expansion using autologous patient serum (obtained from plasmapheresis) have been developed by our group. In this article we propose (1) a total autologous cell culture technique and procedures for cell delivery and (2) a clinical trial with appropriate endpoints structured to determine the efficacy of cellular cardiomyoplasty.
CITATION Ann Thorac Surg. 2004 Mar;77(3):1121-30
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.